期刊文献+

重视阿尔茨海默病的痴呆前阶段 被引量:19

原文传递
导出
摘要 随着人口老龄化进程的加速,阿尔茨海默病(Alzheimer’Sdisease,AD)患病人数逐年增加。流行病学研究显示,65岁以上老年人AD患病率在发达国家为4%~8%,我国为3%~7%。依此推算,我国目前有AD患者600万-800万。在过去的30多年中,全世界对AD研究投入了大量的科研力量,虽然发病机制的研究取得了很大进展,但是近年来针对AD发病机制不同靶点的新药临床试验屡屡失败,到目前为止仍然没有有效的、能阻止AD发生或延缓其进展的药物。究其原因,主要是目前研究仅仅针对AD痴呆阶段(dementiastage)患者,而在这一阶段神经元已经大量死亡,治疗已难以逆转疾病进程。因此,学者们逐渐认识到研究的重点应该转移到AD痴呆前阶段(pre—dementiastage)。
出处 《中华神经科杂志》 CAS CSCD 北大核心 2013年第1期2-4,共3页 Chinese Journal of Neurology
  • 相关文献

参考文献19

  • 1Lobo A, Launer LJ, Fratiglioni L, et al. Prevalence of dementia and major subtypes in Europe : A collaborative study of population- based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology ,2000, 54 ( 11 Suppl 5 ) :S4-9.
  • 2Berr C, Wancata J, Ritchie K. Prevalence of dementia in the elderly in Europe. Eur Neuropsychopharmacol, 2005, 15 : 463 -471.
  • 3Dong MJ, Peng B, Lin XT, et al. The prevalence of dementia in the People' s Republic of China: a systematic analysis of 1980- 2004 studies. Age Ageing, 2007 ,36 :619-624.
  • 4Kalaria RN, Maestre GE, Arizaga R, et al. Alzheimer' s disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol, 2008, 7:812-826.
  • 5Smith AD. Why are drug trials in Alzheimer' s disease failing? Lancet, 2010,376 : 1466.
  • 6Selkoe DJ. Resolving controversies on the path to Alzheimer' s therapeutics. Nat Med, 2011,17 : 1060-1065.
  • 7Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer' s disease: recommendations from the National Institute on Aging-Alzheimer ' s Association workgroups on diagnostic guidelines for Alzheimer' s disease. Alzheimers Dement, 2011,7:280-292.
  • 8McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer' s disease: recommendations from the National Institute on Aging-Alzheimer ' s Association workgroups on diagnostic guidelines for Alzheimer' s disease. Alzheimers Dement, 2011,7 : 263-269.
  • 9Cummings JL, Doody R, Clark C. Disease-modifying therapies for Alzheimer disease: challenges to early intervention. Neurology, 2007,69 : 1622-1634.
  • 10Petersen RC, Thomas RG, Grundman M, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl JMed, 2005,352:2379-2388.

二级参考文献164

  • 1McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer' s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer' s disease. Neurology, 1984, 34:939-944.
  • 2Davis DG, Sehmitt FA, Wekstein DR, et al. Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neumpathol Exp Neurol, 1999, 58:376-388.
  • 3Knopman DS, Parisi JE, Salviati A, et al. Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol, 2003, 62 : 1087-1095.
  • 4Price JL, Morris JC. Tangles and plaques in nondemented aging and "preclinieal" Alzheimer' s disease. Ann Neurol, 1999, 45 : 358 -368.
  • 5Alladi S, Xuereb J, Bak T, et al. Focal cortical presentations of Alzheimer' s disease. Brain, 2007, 130 Pt 10:2636-2645.
  • 6Rabinovici GD, Jagust WJ, Furst A J, et al. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol, 2008, 64:388-401.
  • 7Tang-Wai DF, Graff-Radford NR, Boeve BF, et al. Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology, 2004, 63:1168-1174.
  • 8Khachaturian ZS. Diagnosis of Alzheimer' s disease. Arch Neurol, 1985, 42: 1097-1105.
  • 9Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer' s Disease(CERAD). Part lI. Standardization of the neuropathologic assessment of Alzheimer' s disease. Neurology, 1991,41:479-486.
  • 10Hyman BT. The neuropathological diagnosis of Alzheimer' sdisease : clinical-pathological studies. Neurobiol Aging, 1997, 18 (4 Suppl) : $27-32.

共引文献134

同被引文献126

引证文献19

二级引证文献268

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部